Remarkably, SCA patients with high death risk presented increased levels of IL-10, IP-10, MIP-1α, MIP-1β, and RANTES in comparison with those of SCA patients presenting low death risk. This evidence concerns the gene CCL3 and autosomal dominant cerebellar ataxia.